HA Filler · Juvéderm · Belotero
Face Filler in Seoul
Hyaluronic Acid Dermal Filler
- Duration
- 30-45 min single zone
- Sessions
- 1 session per zone
- Downtime
- Same-day return to non-strenuous activity
HA Filler Treatment in Seoul
HA dermal filler in Gangnam with anatomy-based product selection across Juvéderm and Belotero — restoring volume and contour by zone under a board-certified dermatologist.
- Duration
- 30–45 min single zone / 60–90 min multi-zone
- Sessions
- 1 session per zone
- Downtime
- Same-day light activity; 0–10 days (lips / tear troughs)
- Peak Result
- 2–4 weeks after swelling settles
Results Over Time
HA filler restores volume in the cheeks, tear troughs, lips, nasolabial folds, chin, and jawline — product matched to the zone: high-lift gels for cheek and chin, soft gels for lips, superficial gels for fine lines.
01Immediate (Day 0)
Visible volume on the injection table. Mild swelling and needle marks normal; lips swell more than midface for 24–48 hours.
02Day 1–3
Swelling peaks at 24–48 hours. Possible bruising at lips and tear trough — concealable after Day 2.
03Week 1–2
Swelling resolves; the 2-week appearance is closer to the true outcome. Minor asymmetries addressed at 4-week review.
04Month 1
Settled. Top-up volume added if under-corrected. Photographic comparison with baseline.
05Month 9–18
Gradual loss — longest in cheek, chin, jawline; shortest in lips and perioral. Repeat planned by lifestyle.
Images are AI-generated for illustrative purposes only.
Juvéderm & Belotero
Anatomy-based HA filler across the Juvéderm and Belotero families — both FDA-cleared and MFDS-approved, with brand and lot recorded in a written handover.
Juvéderm VYCROSS
Voluma (high G′) for cheek/chin projection, Vollure for nasolabial folds, Volbella for lips, Volux for jawline — matched by firmness.
Belotero Balance
Merz CPM gel for superficial placement — safe near the eyelids (no Tyndall effect), ideal for perioral lines and tear troughs.
Anatomy-Based Selection
Product matched to the zone: high-lift gels for cheek/chin, soft gels for lips, superficial gels for fine lines.
Treatment Process
01Expert Consultation
Consultation + facial analysis by Dr. SangYoul Yun, with a photographic baseline — and the option to decline filler in favor of Sculptra, JUVELOOK / Rejuran, or surgical referral.
02Pain Management
Topical anesthetic 30–45 min. Most HA products contain integrated lidocaine; nerve blocks optional on request.
03Injection
Injection in a private room. Cannula or needle selected by zone and product. Typical first session: 1–2 syringes.
04Follow-Up Care
Same-day photo review + written record (brand, lot, expiry, zone, volume, instrument), with 1-week and 4-week messenger follow-up.
Recovery & Care
Day 0 (first 4h)
Cold compress at 10-min intervals. Do not press, massage, or manipulate. Sleep with head elevated.
Day 1–3
Avoid alcohol, vigorous exercise, sauna, hot yoga, and facial massage. Mild swelling and small bruises expected.
Day 3–7
Bruises concealable with makeup. Resume exercise. Avoid dental cleaning for 2 weeks. Call immediately for worsening pain, skin-color change, or vision change.
Week 2–4
Final result at the 4-week visit. Resume retinoids and acids. Wait 2+ weeks for RF / ultrasound / laser on the treated zone.
Frequently Asked Questions
Q.Which HA filler brands does Dr. Yun use?
Two brands only — Juvéderm (Allergan / AbbVie) and Belotero (Merz). Both MFDS-approved via licensed Korean distribution. Fewer products means deeper familiarity with each gel's rheology and placement plane. Brand and lot number recorded in your written handover.
Q.Can I complete face filler in a single Seoul trip?
Yes. Schedule: arrival day 1 → consultation + injection day 2-3 → photo review day 4-5 before flying. Lip / tear-trough bruising 5-10 days, concealable with mineral makeup. Plan social events 2+ weeks post-injection.
Q.Will you tell me if I don't need filler?
Yes. Dr. Yun routinely recommends no treatment, Sculptra (diffuse volume loss), JUVELOOK / Rejuran (skin quality), or surgical referral when filler is not the right tool. First-time patients receive 0.5-1.5 mL with 2-4 week reassessment — we do not 'finish' your face in one session.
Q.Is HA filler reversible? What about Voluma?
Partially. Hyaluronidase dissolves HA gel — Belotero and Juvéderm Ultra dissolve readily; Voluma is the most resistant and may need repeat sessions. Non-HA fillers (Sculptra, Radiesse) cannot be dissolved. If reversibility matters, we steer toward more responsive products.
Q.What is BDD and why do you screen for it?
Body dysmorphic disorder is a recognized condition where a person is preoccupied with a flaw others see as minor. International consensus now recommends BDD screening before injectables — patients with BDD typically do not feel better after the procedure. We screen with a brief conversation and decline filler with a respectful referral when present.
Q.How long does HA filler last in each zone?
Cheek and chin 12-24 months (Voluma) · NLF 9-15 months (Vollure) · lips 6-12 months (Volbella) · tear trough 9-18 months (Belotero Balance). Mobile zones wear sooner. These are population ranges — heavy zone-use shortens persistence.
Q.Will my face look obviously 'done'?
Not if product matches zone and volume is conservative. Pillow face comes from cumulative over-treatment with high-G' gels in lips and superficial cheek. Our default is to undertreat in the first session and add at the 4-week review. Prior poorly-placed filler may need partial hyaluronidase before new product.
Q.What is a late-onset filler nodule?
A firm lump appearing weeks to years after injection — distinct from immediate swelling. Increasingly recognized with VYCROSS products. Triggers include systemic immune events (COVID, severe flu, dental abscess), local trauma, or none. Most resolve with hyaluronidase, intralesional steroid, or antibiotics. Report any new lump promptly.
Q.Cannula or needle — which do you use?
Both. Fine needle (27-30G) for precise superficial work (perioral lines, lip border). Blunt cannula for larger-volume zones (22G deep cheek, 25G NLF / tear trough / lip). Instrument selected by zone and product.
References22
The clinical claims on this page — device specs, efficacy timelines, safety profile — are supported by the primary sources below. Each citation links to the original paper or regulatory record.
- [1]Biophysical characteristics of hyaluronic acid soft-tissue fillers. Dermatol Surg (Sundaram) (2013).
- [2]Rheology and physicochemical properties of HA dermal fillers. Int J Mol Sci (Fundarò) (2022).
- [3]Comparative physical properties of 10 HA dermal fillers. Dermatol Surg (Kablik) (2009).
- [4]BDDE crosslinking metabolism and safety profile of HA fillers. Dermatol Surg (De Boulle) (2013).
- [5]Cohesive polydensified matrix (CPM) HA filler characterization. Plast Reconstr Surg (Sundaram) (2015).
- [6]Hyaluronidase response across 12 commercial HA fillers in vitro. J Plast Reconstr Aesthet Surg (Ryu) (2020).
- [7]In-vivo hyaluronidase response by HA filler type. J Plast Reconstr Aesthet Surg (Zhang-Nunes) (2020).
- [8]Voluma cheek 2-year persistence pivotal study. Dermatol Surg (Jones) (2013).
- [9]Voluma zone subanalysis — cheek vs submalar persistence. Dermatol Surg (Glaser) (2015).
- [10]Volbella infraorbital and lip 1-year efficacy and safety. Dermatol Surg (Geronemus) (2017).
- [11]Crosslinked HA stimulates dermal collagen neogenesis. Arch Dermatol (Wang) (2007).
- [12]MRI evaluation of HA persistence at 12 months postinjection. Dermatology (Becker) (2015).
- [13]Korean YYS HA filler prospective postmarketing safety, 1,022 subjects. Dermatol Surg (Park YYS) (2024).
- [14]Update on avoiding and treating blindness from filler — 48 new cases. Aesthet Surg J (Beleznay blindness) (2019).
- [15]Vascular complications of facial filler injection — Asian cohort. Aesthet Plast Surg (Kapoor) (2019).
- [16]Upper-facial ICA-ECA anastomoses — 3D CTA filler safety basis. Aesthet Surg J (Li / Cotofana) (2022).
- [17]Aspiration before tissue filler — exercise in futility analysis. Aesthet Surg J (Goodman aspiration) (2021).
- [18]Aspiration sensitivity in dermal filler injection (33% at 1 sec). J Cosmet Dermatol (Van Loghem) (2018).
- [19]Global Aesthetics Consensus on HA filler use and safety. Plast Reconstr Surg (Global Consensus) (2016).
- [20]AAO 2025 review — 198 cases of filler-related vision loss. Ophthalmology (AAO vision-loss) (2025).
- [21]Late-onset filler nodules — VYCROSS pattern and management. J Clin Aesthet Dermatol (Wong / Sclafani) (2021).
- [22]Filler complications and BDD screening — current standard of care. Aesthet Plast Surg (BDD screening) (2024).
Notice
- Pregnancy or breastfeeding
- Active skin infection, cold sore (HSV), or inflammatory acne at injection site
- Known hypersensitivity to hyaluronic acid, lidocaine, or BDDE crosslinker
- Recent dental work or vaccination within 2-4 weeks at the site
- Active autoimmune flare or therapeutic anticoagulation — reviewed at consultation
- Single-session full-face requests or unrealistic expectations — declined respectfully
Session summary & comparison
| Item | Details |
|---|---|
| Duration | 30-45 min single zone · 60-90 min multi-zone consultation + injection + review |
| Sessions | 1 session per zone · refresh every 9-18 months depending on zone and product |
| Downtime | Same-day return to non-strenuous activity · bruising 0-10 days lip / tear trough |
| Peak result | 2-4 weeks after swelling settles |
Related procedures
Evidence & comparison guides
Notice: Individual results may vary depending on skin condition, treatment history, and recovery factors. All treatment plans are determined through individual consultation with a board-certified dermatologist. The information on this page is for reference only and does not constitute medical advice or guarantee specific outcomes.
Next Step